Abstract
Background Left ventricular diastolic dysfunction in chronic thromboembolic pulmonary hypertension is classically attributed to the negative effects of pulmonary hypertension on left ventricular filling. Recent evidence, however, suggests diastolic dysfunction may exist independent of pulmonary hypertension and moreover may be masked by an under-filled left ventricle.
Methods Consecutive patients undergoing pulmonary endarterectomy (2007 – 2018) were included (n=1266). Left ventricular diastolic dysfunction was assessed using pulmonary arterial wedge pressure and in nested cohorts utilising multi-modal cardiac imaging. Diagnostic baseline, outcome data, and long-term mortality outcomes were assessed.
Results 135 individuals had a wedge pressure >15mmHg following surgery, of whom 60% had a normal wedge pressure pre-operatively. No patients had a formal diagnosis of heart-failure preserved ejection fraction. Haemodynamic, functional and patient-related outcomes were all worse in this patient subgroup and associated with a higher requirement for peri-operative non-invasive ventilation and impaired long-term survival. Post-operative cardiac imaging confirmed evidence of left ventricular diastolic dysfunction in patients with an elevated wedge pressure. Pre-operative left atrial dilatation alone predicted post-operative wedge elevation with accuracy (sensitivity 67%, specificity 100%), and was superior to echocardiography.
Conclusions Left ventricular diastolic dysfunction is strongly associated with all pulmonary endarterectomy outcome measures, however the majority of patients do not have an elevated wedge pressure pre-operatively and are not diagnosed with heart failure. Standard pre-operative work-up should include assessment for diastolic dysfunction to aid risk categorisation and guide therapy decisions.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The ethic committee of Royal Papworth Hospital, UK waived ethical approval for this study. Patient data was de-identified prior to use in this study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript
Abbreviations
- CMR
- Cardiac magnetic resonance
- CTEPH
- Chronic thromboembolic pulmonary hypertension
- HFpEF
- Heart failure preserved ejection fraction
- LV
- Left ventricle
- LVDD
- Left ventricular diastolic dysfunction
- LVEDP
- Left ventricular end-diastolic pressure
- PAWP
- Pulmonary arterial wedge pressure
- PEA
- Pulmonary endarterectomy
- PH
- Pulmonary hypertension
- PRO
- Patient Reported Outcome
- PVR
- Pulmonary vascular resistance
- RV
- Right ventricle





